# Rithm Capital Corp.: financial statements, quarterly

RITM · NYSE · CIK 1556593 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ritm.md) · [Financials](/companies/ritm/financials.md) · [Filings](/companies/ritm/filings.md) · [Insiders](/companies/ritm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ritm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,135](/filings/0001556593-24-000041.md) | [692](/filings/0001556593-24-000027.md) | [1,185](/filings/0001556593-24-000028.md) | [1,155](/filings/0001556593-25-000024.md) | [999](/filings/0001556593-25-000033.md) | [1,567 d](/filings/0001556593-26-000012.md) | [977](/filings/0001556593-26-000023.md) | [1,220](/filings/0001556593-26-000029.md) | [1,106](/filings/0001556593-25-000033.md) | [1,291 d](/filings/0001556593-26-000012.md) | [1,380](/filings/0001556593-26-000023.md) | [1,282](/filings/0001556593-26-000029.md) |
| Interest expense | $m | [383](/filings/0001556593-23-000031.md) | [400 d](/filings/0001556593-24-000007.md) | [414](/filings/0001556593-24-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [52.6](/filings/0001556593-24-000041.md) | [29.9](/filings/0001556593-24-000027.md) | [93.4](/filings/0001556593-25-000016.md) | [51.6](/filings/0001556593-25-000024.md) | [(78.4)](/filings/0001556593-25-000033.md) | [201 d](/filings/0001556593-26-000012.md) | [(23.9)](/filings/0001556593-26-000023.md) | [(11.6)](/filings/0001556593-26-000029.md) | [8.1](/filings/0001556593-25-000033.md) | [116 d](/filings/0001556593-26-000012.md) | [44.8](/filings/0001556593-26-000023.md) | [19.0](/filings/0001556593-26-000029.md) |
| Net income | $m | [221](/filings/0001556593-24-000041.md) | [(67.2)](/filings/0001556593-24-000027.md) | [284](/filings/0001556593-25-000016.md) | [236](/filings/0001556593-25-000024.md) | [122](/filings/0001556593-25-000033.md) | [290 d](/filings/0001556593-26-000012.md) | [78.8](/filings/0001556593-26-000023.md) | [312](/filings/0001556593-26-000029.md) | [222](/filings/0001556593-25-000033.md) | [85.0 d](/filings/0001556593-26-000012.md) | [103](/filings/0001556593-26-000023.md) | [56.3](/filings/0001556593-26-000029.md) |
| Diluted EPS | $ per share | [0.40](/filings/0001556593-24-000041.md) | [(0.18)](/filings/0001556593-24-000027.md) | [0.54](/filings/0001556593-25-000016.md) | [0.43](/filings/0001556593-25-000024.md) | [0.20](/filings/0001556593-25-000033.md) | not reported | [0.07](/filings/0001556593-26-000023.md) | [0.53](/filings/0001556593-26-000029.md) | [0.35](/filings/0001556593-25-000033.md) | not reported | [0.12](/filings/0001556593-26-000023.md) | [0.04](/filings/0001556593-26-000029.md) |
| Basic EPS | $ per share | [0.40](/filings/0001556593-24-000041.md) | [(0.18)](/filings/0001556593-24-000027.md) | [0.54](/filings/0001556593-25-000016.md) | [0.44](/filings/0001556593-25-000024.md) | [0.20](/filings/0001556593-25-000033.md) | not reported | [0.07](/filings/0001556593-26-000023.md) | [0.54](/filings/0001556593-26-000029.md) | [0.36](/filings/0001556593-25-000033.md) | not reported | [0.12](/filings/0001556593-26-000023.md) | [0.04](/filings/0001556593-26-000029.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.2](/filings/0001556593-24-000027.md) | [1.3](/filings/0001556593-25-000007.md) | [1.1](/filings/0001556593-24-000028.md) | [1.2](/filings/0001556593-24-000029.md) | [1.6](/filings/0001556593-24-000041.md) | [1.5](/filings/0001556593-26-000012.md) | [1.5](/filings/0001556593-25-000016.md) | [1.6](/filings/0001556593-25-000024.md) | [1.6](/filings/0001556593-25-000033.md) | [1.8](/filings/0001556593-26-000029.md) | [1.6](/filings/0001556593-26-000023.md) | [1.7](/filings/0001556593-26-000029.md) |
| Total assets | $bn | [36.8](/filings/0001556593-24-000027.md) | [39.7](/filings/0001556593-26-000012.md) | [47.9](/filings/0001556593-24-000028.md) | [42.0](/filings/0001556593-24-000029.md) | [42.3](/filings/0001556593-24-000041.md) | [46.0](/filings/0001556593-26-000012.md) | [45.3](/filings/0001556593-25-000016.md) | [44.3](/filings/0001556593-25-000024.md) | [47.2](/filings/0001556593-25-000033.md) | [53.1](/filings/0001556593-26-000029.md) | [53.4](/filings/0001556593-26-000023.md) | [54.1](/filings/0001556593-26-000029.md) |
| Total liabilities | $bn | [29.5](/filings/0001556593-24-000027.md) | [32.6](/filings/0001556593-26-000012.md) | [40.7](/filings/0001556593-24-000028.md) | [34.6](/filings/0001556593-24-000029.md) | [34.5](/filings/0001556593-24-000041.md) | [38.2](/filings/0001556593-26-000012.md) | [37.2](/filings/0001556593-25-000016.md) | [36.0](/filings/0001556593-25-000024.md) | [38.3](/filings/0001556593-25-000033.md) | [43.8](/filings/0001556593-26-000029.md) | [43.9](/filings/0001556593-26-000023.md) | [44.7](/filings/0001556593-26-000029.md) |
| Long-term debt | $bn | [24.2](/filings/0001556593-23-000031.md) | [27.0](/filings/0001556593-24-000027.md) | [32.7](/filings/0001556593-24-000028.md) | [30.1](/filings/0001556593-24-000029.md) | [29.6](/filings/0001556593-24-000041.md) | [32.6](/filings/0001556593-25-000007.md) | [32.2](/filings/0001556593-25-000016.md) | [31.2](/filings/0001556593-25-000024.md) | [32.2](/filings/0001556593-25-000033.md) | [35.4](/filings/0001556593-26-000012.md) | [35.2](/filings/0001556593-26-000023.md) | [36.0](/filings/0001556593-26-000029.md) |
| Shareholders' equity | $bn | [7.2](/filings/0001556593-24-000027.md) | [7.0](/filings/0001556593-26-000012.md) | [7.1](/filings/0001556593-24-000028.md) | [7.3](/filings/0001556593-24-000029.md) | [7.7](/filings/0001556593-24-000041.md) | [7.8](/filings/0001556593-26-000012.md) | [7.8](/filings/0001556593-25-000016.md) | [7.9](/filings/0001556593-25-000024.md) | [8.5](/filings/0001556593-25-000033.md) | [8.4](/filings/0001556593-26-000029.md) | [8.6](/filings/0001556593-26-000023.md) | [8.5](/filings/0001556593-26-000029.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [509 d](/filings/0001556593-24-000041.md) | [(1,047) d](/filings/0001556593-26-000012.md) | [(1,315)](/filings/0001556593-25-000016.md) | [115 d](/filings/0001556593-25-000024.md) | [768 d](/filings/0001556593-25-000033.md) | [(1,753) d](/filings/0001556593-26-000012.md) | [1,421](/filings/0001556593-26-000023.md) | [(557) d](/filings/0001556593-26-000029.md) | [(2,042) d](/filings/0001556593-25-000033.md) | [(115) d](/filings/0001556593-26-000012.md) | [101](/filings/0001556593-26-000023.md) | [174 d](/filings/0001556593-26-000029.md) |
| Dividends paid | $m | [143 d](/filings/0001556593-23-000031.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [483](/filings/0001556593-24-000028.md) | [483](/filings/0001556593-24-000029.md) | [484](/filings/0001556593-24-000041.md) | [484](/filings/0001556593-24-000027.md) | [486](/filings/0001556593-25-000016.md) | [491](/filings/0001556593-25-000024.md) | [497](/filings/0001556593-25-000033.md) | [531](/filings/0001556593-26-000023.md) | [537](/filings/0001556593-26-000029.md) | [551](/filings/0001556593-25-000033.md) | [566](/filings/0001556593-26-000023.md) | [568](/filings/0001556593-26-000029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 558,407,031 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001556593-26-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.